IL49215A0 - Sustained release pharmaceutical formulation - Google Patents

Sustained release pharmaceutical formulation

Info

Publication number
IL49215A0
IL49215A0 IL49215A IL4921576A IL49215A0 IL 49215 A0 IL49215 A0 IL 49215A0 IL 49215 A IL49215 A IL 49215A IL 4921576 A IL4921576 A IL 4921576A IL 49215 A0 IL49215 A0 IL 49215A0
Authority
IL
Israel
Prior art keywords
sustained release
pharmaceutical formulation
release pharmaceutical
formulation
sustained
Prior art date
Application number
IL49215A
Other versions
IL49215A (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL49215A0 publication Critical patent/IL49215A0/en
Publication of IL49215A publication Critical patent/IL49215A/en

Links

IL49215A 1975-03-17 1976-03-15 Sustained release pharmaceutical formulation floating in the gastric fluid IL49215A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13

Publications (2)

Publication Number Publication Date
IL49215A0 true IL49215A0 (en) 1976-05-31
IL49215A IL49215A (en) 1979-09-30

Family

ID=27071951

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49215A IL49215A (en) 1975-03-17 1976-03-15 Sustained release pharmaceutical formulation floating in the gastric fluid

Country Status (2)

Country Link
IL (1) IL49215A (en)
NO (1) NO145261C (en)

Also Published As

Publication number Publication date
NO760928L (en) 1976-09-20
IL49215A (en) 1979-09-30
NO145261C (en) 1982-02-17
NO145261B (en) 1981-11-09

Similar Documents

Publication Publication Date Title
NZ180321A (en) Sustained release pharmaceutical preparation
ZA7671B (en) Pharmaceutical composition
KE3120A (en) Sustained release pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
KE3219A (en) Pharmaceutical compositions
GB1549171A (en) Pharmaceutical formulations containing hydrocy bezophenonederivatives
AU1306576A (en) Pharmaceutical formulation
PT67323A (en) Prolonged release pharmaceutical preparations
ZA76829B (en) Tablet formulation
ZA761305B (en) Sustained release formulation
GB1539031A (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
ZA767215B (en) Pharmaceutical compositions
ZA761880B (en) New pharmaceutical compositions
ZA767193B (en) Pharmaceutical antifertility-combinations
IL49215A0 (en) Sustained release pharmaceutical formulation
IE43955L (en) Pharmaceutical composition
ZA763806B (en) Pharmaceutical compositions
IL47592A0 (en) Controlled drug releasing preparation
ZA755515B (en) Pharmaceutical formulations
IL49355A0 (en) Pharmaceutical compositions comprising sodium-l-ascorbate-2-sulfate
ZA752585B (en) Pharmaceutical composition
AU1172076A (en) Pharmaceutical compositions
ZA7627B (en) Pharmaceutical combination preparations
NZ179859A (en) 2-phenyl-pyrol(id)in-4-yl -pyridine derivatives and pharmaceutical compositions